It is a pharma private limited company based in Chandigarh, Chandigarh, India, established in 2012.
2012 | Chandigarh, Chandigarh, India | ActiveMax-Bio Biosciences Private Limited, a active private limited company, was established on 04 June 2012 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232CH2012PTC033839. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Indian Biomax Private Limited, Biomax Biosciences Private Limited. It upholds a compliant status. Its leadership includes Jatin Kumar (Director), Rakesh Kumar (Director), Surinder Kumar Kalra (Director). Past directors included Mohit Chaudhary, Jatin Kumar, Abhishek Kumar. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at T-4, Third Floor, Centra Mall, Ind. Area, Phase-1, Chandigarh, Chandigarh, Chandigarh, 160002.
U24232CH2012PTC033839
033839
04 June 2012
₹0.10 M
₹0.10 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Max-Bio Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jatin Kumar | Director | 10 Aug 2022 | Current |
| Rakesh Kumar | Director | 02 Aug 2024 | Current |
| Surinder Kumar Kalra | Director | 19 Sep 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Aug 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
| Pramod Abcsdd | Director | 11 Aug 2022 | Past |
| Pramod Abcsdd | Director | 11 Aug 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Max-Bio Biosciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 89.53% increase in profit. The company's net worth dipped by a decrease of 1.18%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Max-Bio Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Max-Bio Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Max-Bio Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Max-Bio Biosciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Surinder Kumar Kalra was appointed as a Director was appointed as a Director on 19 Sep 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.
The activity Rakesh Kumar was appointed as a Director was appointed as a Director on 02 Aug 2024 & has been associated with this company since 1 year 3 months . was completed.
The activity Max-Bio Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
The activity Max-Bio Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chandigarh. was completed.
Jatin Kumar was appointed as a Director was appointed as a Director on 10 Aug 2022 & has been associated with this company since 3 years 3 months . was recorded as a recent event.
Progress on Max-Bio Biosciences Private Limited was registered on 04 Jun 2012 with Roc Chandigarh & aged 13 years 5 months as per MCA records. was documented.
The CIN of Max-Bio Biosciences Private Limited is U24232CH2012PTC033839.
Max-Bio Biosciences Private Limited is headquartered at T-4, Third Floor, Centra Mall, Ind. Area, Phase-1, Chandigarh, Chandigarh, Chandigarh, 160002.
Max-Bio Biosciences Private Limited was incorporated on 04 June 2012.
The current directors of Max-Bio Biosciences Private Limited are
The primary industry of Max-Bio Biosciences Private Limited is Trade.
Max-Bio Biosciences Private Limited is unlisted.
The authorized capital of Max-Bio Biosciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Max-Bio Biosciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX